메뉴 건너뛰기




Volumn 125, Issue 5, 2012, Pages 372-381

Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment

Author keywords

Antipsychotics; Polypharmacy; Schizophrenia; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; TRANQUILIZER;

EID: 84859849156     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2012.01835.x     Document Type: Article
Times cited : (48)

References (47)
  • 1
    • 24944521199 scopus 로고    scopus 로고
    • Schizophrenia practice guidelines: international survey and comparison
    • Gaebel W, Weinmann S, Sartorius N, Rutz W, McIntyre JS. Schizophrenia practice guidelines: international survey and comparison. BJPsych 2005;187:248-255.
    • (2005) BJPsych , vol.187 , pp. 248-255
    • Gaebel, W.1    Weinmann, S.2    Sartorius, N.3    Rutz, W.4    McIntyre, J.S.5
  • 2
    • 0004050325 scopus 로고    scopus 로고
    • American Psychiatric Association., 2nd edn. Arlington, VA: American Psychiatric Association
    • American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia, 2nd edn. Arlington, VA: American Psychiatric Association, 2004.
    • (2004) Practice guideline for the treatment of patients with schizophrenia
  • 3
    • 73949157937 scopus 로고    scopus 로고
    • The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009
    • Kreyenbuhl J, Buchanan R, Dickerson FB, Dixon LB. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. Schizophr Bull 2010;36:94-103.
    • (2010) Schizophr Bull , vol.36 , pp. 94-103
    • Kreyenbuhl, J.1    Buchanan, R.2    Dickerson, F.B.3    Dixon, L.B.4
  • 4
    • 1842533044 scopus 로고    scopus 로고
    • Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits
    • Centorrino F, Goren JL, Hennen J, Salvatore P, Kelleher JP, Baldessarini RJ. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry 2004;161:700-706.
    • (2004) Am J Psychiatry , vol.161 , pp. 700-706
    • Centorrino, F.1    Goren, J.L.2    Hennen, J.3    Salvatore, P.4    Kelleher, J.P.5    Baldessarini, R.J.6
  • 6
    • 65349112410 scopus 로고    scopus 로고
    • Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials
    • Correll CU, Rummel-Kluge C, Corves C, Kane JM, Leucht S. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Bull 2009;35:443-457.
    • (2009) Schizophr Bull , vol.35 , pp. 443-457
    • Correll, C.U.1    Rummel-Kluge, C.2    Corves, C.3    Kane, J.M.4    Leucht, S.5
  • 7
    • 85016038379 scopus 로고    scopus 로고
    • Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia
    • Cipriani A, Boso M, Barbui C. Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. Cochrane Database Syst Rev 2009;8(3):CD006324.
    • (2009) Cochrane Database Syst Rev , vol.8 , Issue.3
    • Cipriani, A.1    Boso, M.2    Barbui, C.3
  • 8
    • 65849514380 scopus 로고    scopus 로고
    • Polypharmacy with second-generation antipsychotics: a review of evidence
    • Pandurangi AK, Dalkilic A. Polypharmacy with second-generation antipsychotics: a review of evidence. J Psychiatr Pract 2008;14:345-367.
    • (2008) J Psychiatr Pract , vol.14 , pp. 345-367
    • Pandurangi, A.K.1    Dalkilic, A.2
  • 9
    • 26844433208 scopus 로고    scopus 로고
    • Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
    • Faries D, Ascher-Svanum H, Zhu B, Correll C, Kane J. Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics. BMC Psychiatry 2005;5:26.
    • (2005) BMC Psychiatry , vol.5 , pp. 26
    • Faries, D.1    Ascher-Svanum, H.2    Zhu, B.3    Correll, C.4    Kane, J.5
  • 10
    • 1242329378 scopus 로고    scopus 로고
    • A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation
    • Stahl SM, Grady MM. A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. Curr Med Chem 2004;11:313-326.
    • (2004) Curr Med Chem , vol.11 , pp. 313-326
    • Stahl, S.M.1    Grady, M.M.2
  • 11
    • 77957341547 scopus 로고    scopus 로고
    • Evaluation of a multifaceted intervention to limit excessive antipsychotic co-prescribing in schizophrenia out-patients
    • Baandrup L, Allerup P, Lublin H, Nordentoft M, Peacock L, Glenthoj B. Evaluation of a multifaceted intervention to limit excessive antipsychotic co-prescribing in schizophrenia out-patients. Acta Psychiatr Scand 2010;122:367-374.
    • (2010) Acta Psychiatr Scand , vol.122 , pp. 367-374
    • Baandrup, L.1    Allerup, P.2    Lublin, H.3    Nordentoft, M.4    Peacock, L.5    Glenthoj, B.6
  • 12
    • 72249120193 scopus 로고    scopus 로고
    • Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies
    • Verdoux H, Tour M. Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand 2010;121:4-10.
    • (2010) Acta Psychiatr Scand , vol.121 , pp. 4-10
    • Verdoux, H.1    Tour, M.2
  • 13
    • 0035988519 scopus 로고    scopus 로고
    • Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy
    • Clark RE, Bartels SJ, Mellman TA, Peacock WJ. Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy. Schizophr Bull 2002;28:75-84.
    • (2002) Schizophr Bull , vol.28 , pp. 75-84
    • Clark, R.E.1    Bartels, S.J.2    Mellman, T.A.3    Peacock, W.J.4
  • 15
    • 77957348105 scopus 로고    scopus 로고
    • 10-year trends in the treatment and outcomes of patients with first-episode schizophrenia
    • Nielsen J, Le Quach P, Emborg C, Foldager L, Correll CU. 10-year trends in the treatment and outcomes of patients with first-episode schizophrenia. Acta Psychiatr Scand 2010;122:356-366.
    • (2010) Acta Psychiatr Scand , vol.122 , pp. 356-366
    • Nielsen, J.1    Le Quach, P.2    Emborg, C.3    Foldager, L.4    Correll, C.U.5
  • 17
    • 73649097613 scopus 로고    scopus 로고
    • National trends in psychotropic medication polypharmacy in office-based psychiatry
    • Mojtabai R, Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry 2010;67:26-36.
    • (2010) Arch Gen Psychiatry , vol.67 , pp. 26-36
    • Mojtabai, R.1    Olfson, M.2
  • 18
    • 34247371922 scopus 로고    scopus 로고
    • Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns
    • Kreyenbuhl JA, Valenstein M, Mccarthy JF, Ganoczy D, Blow FC. Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns. Psychiatr Serv 2006;58:489-495.
    • (2006) Psychiatr Serv , vol.58 , pp. 489-495
    • Kreyenbuhl, J.A.1    Valenstein, M.2    Mccarthy, J.F.3    Ganoczy, D.4    Blow, F.C.5
  • 19
  • 20
    • 65349163482 scopus 로고    scopus 로고
    • Does the addition of a second antipsychotic drug improve clozapine treatment?
    • Barbui C, Signoretti A, Mule S, Boso M, Cipriani A. Does the addition of a second antipsychotic drug improve clozapine treatment? Schizophr Bull 2009;35:458-468.
    • (2009) Schizophr Bull , vol.35 , pp. 458-468
    • Barbui, C.1    Signoretti, A.2    Mule, S.3    Boso, M.4    Cipriani, A.5
  • 21
    • 67649695935 scopus 로고    scopus 로고
    • Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study
    • Kroken RA, Johnsen E, Ruud T, Wentzel-Larsen T, Jorgensen HA. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry 2009;9:24.
    • (2009) BMC Psychiatry , vol.9 , pp. 24
    • Kroken, R.A.1    Johnsen, E.2    Ruud, T.3    Wentzel-Larsen, T.4    Jorgensen, H.A.5
  • 22
    • 0036838758 scopus 로고    scopus 로고
    • Antipsychotic combination therapy in schizophrenia: a review of efficacy and risks of current combinations
    • Freudenreich O, Goff DC. Antipsychotic combination therapy in schizophrenia: a review of efficacy and risks of current combinations. Acta Psychiatr Scand 2002;106:323-330.
    • (2002) Acta Psychiatr Scand , vol.106 , pp. 323-330
    • Freudenreich, O.1    Goff, D.C.2
  • 23
    • 79960551424 scopus 로고    scopus 로고
    • Effectiveness of switching from antipsychotic polypharmacy to monotherapy
    • Essock SM, Schooler NR, Stroup TS et al. Effectiveness of switching from antipsychotic polypharmacy to monotherapy. Am J Psychiatry 2011;168:702-708.
    • (2011) Am J Psychiatry , vol.168 , pp. 702-708
    • Essock, S.M.1    Schooler, N.R.2    Stroup, T.S.3
  • 24
    • 73949137552 scopus 로고    scopus 로고
    • The 2009 schizophrenia PORT psychopharmacological treatment recommendation and summary statements
    • Buchanan RW, Kreyenbuhl J, Kelly DL et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendation and summary statements. Schizophr Bull 2010;36:71-93.
    • (2010) Schizophr Bull , vol.36 , pp. 71-93
    • Buchanan, R.W.1    Kreyenbuhl, J.2    Kelly, D.L.3
  • 25
    • 0024760391 scopus 로고
    • The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation
    • Kay SR, Opler LA, Lindemeyer JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry 1989;155:59-65.
    • (1989) Br J Psychiatry , vol.155 , pp. 59-65
    • Kay, S.R.1    Opler, L.A.2    Lindemeyer, J.P.3
  • 26
    • 0004235298 scopus 로고    scopus 로고
    • American Psychiatric Association., 4th edn, Text Revision. Edited by Washington DC: American Psychiatric Association
    • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn, Text Revision. Edited by Washington DC: American Psychiatric Association, 2000.
    • (2000) Diagnostic and statistical manual of mental disorders
  • 27
    • 0014723449 scopus 로고
    • A rating scale for extrapyramidal side effects
    • Simpson G, Angus J. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970;212:11-19.
    • (1970) Acta Psychiatr Scand , vol.212 , pp. 11-19
    • Simpson, G.1    Angus, J.2
  • 28
  • 29
    • 0033660612 scopus 로고    scopus 로고
    • Quality of life in schizophrenia: development, reliability and internal consistency of the Lancashire Quality of Life Profile - European Version. EPSILON Study 8. European Psychiatric Services: inputs linked to outcome domains and needs
    • Gaite L, Vázquez-Barquero JL, Arrizabalaga A et al. Quality of life in schizophrenia: development, reliability and internal consistency of the Lancashire Quality of Life Profile - European Version. EPSILON Study 8. European Psychiatric Services: inputs linked to outcome domains and needs. Br J Psychiatry Suppl 2000;39:s49-s54.
    • (2000) Br J Psychiatry Suppl , vol.39
    • Gaite, L.1    Vázquez-Barquero, J.L.2    Arrizabalaga, A.3
  • 30
    • 0034607573 scopus 로고    scopus 로고
    • Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses
    • Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000;42:241-247.
    • (2000) Schizophr Res , vol.42 , pp. 241-247
    • Thompson, K.1    Kulkarni, J.2    Sergejew, A.A.3
  • 31
    • 0033937434 scopus 로고    scopus 로고
    • Client Sociodemographic and Service Receipt Inventory- European Version
    • Chisholm D, Knapp M, Knudsen HC et al. Client Sociodemographic and Service Receipt Inventory- European Version. Br J Psychiatry Suppl 2000;39:S28-S33.
    • (2000) Br J Psychiatry Suppl , vol.39
    • Chisholm, D.1    Knapp, M.2    Knudsen, H.C.3
  • 32
    • 0038266756 scopus 로고    scopus 로고
    • Chlorpromazine equivalent doses for the newer atypical antipsychotics
    • Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64:663-667.
    • (2003) J Clin Psychiatry , vol.64 , pp. 663-667
    • Woods, S.W.1
  • 33
    • 73549110068 scopus 로고    scopus 로고
    • Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs
    • Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 2010;67:255-262.
    • (2010) Biol Psychiatry , vol.67 , pp. 255-262
    • Andreasen, N.C.1    Pressler, M.2    Nopoulos, P.3    Miller, D.4    Ho, B.C.5
  • 35
    • 0030912203 scopus 로고    scopus 로고
    • Chlorpromazine equivalents: a consensus of opinion for both clinical and research
    • Atkins M, Burgess A, Bottomley C, Riccio M. Chlorpromazine equivalents: a consensus of opinion for both clinical and research. Psychiatr Bull 1997;21:224-226.
    • (1997) Psychiatr Bull , vol.21 , pp. 224-226
    • Atkins, M.1    Burgess, A.2    Bottomley, C.3    Riccio, M.4
  • 36
    • 34547685932 scopus 로고    scopus 로고
    • Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses
    • Swanson JM, Hinshaw SP, Arnold LE et al. Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry 2007;46:1003-1014.
    • (2007) J Am Acad Child Adolesc Psychiatry , vol.46 , pp. 1003-1014
    • Swanson, J.M.1    Hinshaw, S.P.2    Arnold, L.E.3
  • 37
    • 21244503152 scopus 로고    scopus 로고
    • The effects of antipsychotic treatment on quality of life of schizophrenic patients under naturalistic treatment conditions: an application of random effect regression models and propensity scores in an observational prospective trial
    • Kilian R, Angermeyer MC. The effects of antipsychotic treatment on quality of life of schizophrenic patients under naturalistic treatment conditions: an application of random effect regression models and propensity scores in an observational prospective trial. Qual Life Res 2005;14:1275-1289.
    • (2005) Qual Life Res , vol.14 , pp. 1275-1289
    • Kilian, R.1    Angermeyer, M.C.2
  • 38
    • 3543135271 scopus 로고    scopus 로고
    • Tutorial in biostatistics. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
    • D'agostino RB. Tutorial in biostatistics. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-2281.
    • (1998) Stat Med , vol.17 , pp. 2265-2281
    • D'agostino, R.B.1
  • 39
    • 0004296209 scopus 로고    scopus 로고
    • 5th edn. Upper Saddle River: Prentice Hall
    • Greene WH. Econometric analysis, 5th edn. Upper Saddle River: Prentice Hall, 2003.
    • (2003) Econometric analysis
    • Greene, W.H.1
  • 40
    • 31644450063 scopus 로고    scopus 로고
    • Stata Corporation. College Station, TX: StataCorp LP
    • Stata Corporation. Stata statistical software: release 10. College Station, TX: StataCorp LP, 2007.
    • (2007) Stata statistical software: release 10
  • 41
    • 77952633076 scopus 로고    scopus 로고
    • Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients
    • Procyshyn RM, Honer WG, Wu TK et al. Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients. J Clin Psychiatry 2010;71:566-573.
    • (2010) J Clin Psychiatry , vol.71 , pp. 566-573
    • Procyshyn, R.M.1    Honer, W.G.2    Wu, T.K.3
  • 42
    • 77649122136 scopus 로고    scopus 로고
    • Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study
    • Baandrup L, Gasse C, Jensen VD et al. Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study. J Clin Psychiatry 2010;71:103-108.
    • (2010) J Clin Psychiatry , vol.71 , pp. 103-108
    • Baandrup, L.1    Gasse, C.2    Jensen, V.D.3
  • 43
    • 78649331683 scopus 로고    scopus 로고
    • Trends in adult antipsychotic polypharmacy: progress and challenges in Florida's Medicaid Program
    • Constantine RJ, Andel R, Tandon R. Trends in adult antipsychotic polypharmacy: progress and challenges in Florida's Medicaid Program. Community Ment Health J 2010;46:523-530.
    • (2010) Community Ment Health J , vol.46 , pp. 523-530
    • Constantine, R.J.1    Andel, R.2    Tandon, R.3
  • 45
    • 0036839285 scopus 로고    scopus 로고
    • Antipsychotic polypharmacy, evidence based or eminence based?
    • Stahl SM. Antipsychotic polypharmacy, evidence based or eminence based? Acta Psychiatr Scand 2002;106:321-323.
    • (2002) Acta Psychiatr Scand , vol.106 , pp. 321-323
    • Stahl, S.M.1
  • 46
    • 0034509321 scopus 로고    scopus 로고
    • Long-term course of schizophrenic, affective and schizoaffective psychosis: focus on negative symptoms and their impact on global indicators of outcome
    • Möller HJ, Bottlender R, Wegner U, Wittmann J, Strauss A. Long-term course of schizophrenic, affective and schizoaffective psychosis: focus on negative symptoms and their impact on global indicators of outcome. Acta Psychiatr Scand 2000;407:54-57.
    • (2000) Acta Psychiatr Scand , vol.407 , pp. 54-57
    • Möller, H.J.1    Bottlender, R.2    Wegner, U.3    Wittmann, J.4    Strauss, A.5
  • 47
    • 0033763239 scopus 로고    scopus 로고
    • Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms
    • Harrow M, Grossman LS, Herbener ES, Davies EW. Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms. Br J Psychiatry 2000;177:421-426.
    • (2000) Br J Psychiatry , vol.177 , pp. 421-426
    • Harrow, M.1    Grossman, L.S.2    Herbener, E.S.3    Davies, E.W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.